Free Trial

BioAtla (BCAB) Short Interest Ratio & Short Volume

BioAtla logo
$0.50 +0.01 (+3.04%)
As of 11:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BioAtla Short Interest Data

BioAtla (BCAB) has a short interest of 4.06 million shares, representing 9.49% of the float (the number of shares available for trading by the public). This marks a -6.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 978,835 shares to cover all short positions.

Current Short Interest
4,060,000 shares
Previous Short Interest
4,330,000 shares
Change Vs. Previous Month
-6.24%
Dollar Volume Sold Short
$1.29 million
Short Interest Ratio
5.7 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
58,401,000 shares
Short Percent of Float
9.49%
Today's Trading Volume
80,334 shares
Average Trading Volume
978,835 shares
Today's Volume Vs. Average
8%
Short Selling BioAtla?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioAtla and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BCAB Short Interest Over Time

BCAB Days to Cover Over Time

BCAB Percentage of Float Shorted Over Time

BioAtla Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20254,060,000 shares $1.29 million -6.2%9.5%5.7 $0.32
3/31/20254,330,000 shares $1.50 million +2.6%10.1%5.2 $0.35
3/15/20254,220,000 shares $1.45 million +32.7%9.9%4 $0.34
2/28/20253,180,000 shares $1.04 million -17.0%7.4%2.9 $0.33
2/15/20253,830,000 shares $1.78 million -12.6%9.0%3.7 $0.46
1/31/20254,380,000 shares $2.06 million -13.4%N/A3.9 $0.47
1/15/20255,060,000 shares $2.44 million +15.0%N/A4.6 $0.48
12/31/20244,400,000 shares $2.60 million +11.4%N/A3.9 $0.59
12/15/20243,950,000 shares $5.73 million -0.8%N/A3 $1.45
11/30/20243,980,000 shares $6.69 million -3.9%N/A3.4 $1.68
11/15/20244,140,000 shares $6.46 million -15.0%N/A3.5 $1.56
10/31/20244,870,000 shares $9.35 million -7.1%N/A4 $1.92
10/15/20245,240,000 shares $10.22 million +17.2%N/A4.4 $1.95
9/30/20244,470,000 shares $7.87 million +0.5%N/A3.8 $1.76
9/15/20244,450,000 shares $8.05 million No ChangeN/A4.9 $1.81
8/31/20244,450,000 shares $7.88 million -6.3%N/A5 $1.77
8/15/20244,750,000 shares $8.93 million +18.8%N/A5 $1.88
7/31/20244,000,000 shares $7.24 million +0.5%N/A4.7 $1.81
7/15/20243,980,000 shares $6.97 million -24.2%N/A4.5 $1.75
6/30/20245,250,000 shares $7.19 million -3.3%N/A6.4 $1.37
6/15/20245,430,000 shares $8.63 million +0.6%N/A7 $1.59
5/31/20245,400,000 shares $8.15 million +3.9%N/A7.1 $1.51
5/15/20245,200,000 shares $15.60 million -2.4%N/A7.4 $3.00
4/30/20245,330,000 shares $12.02 million -1.7%N/A8.8 $2.26
4/15/20245,420,000 shares $15.50 million -3.0%N/A10.1 $2.86
3/31/20245,590,000 shares $19.23 million +9.0%N/A10.9 $3.44
3/15/20245,130,000 shares $12.52 million +0.4%N/A11.6 $2.44
2/29/20245,110,000 shares $13.80 million +1.4%N/A11 $2.70
2/15/20245,040,000 shares $13.36 million +6.6%N/A9.6 $2.65
1/31/20244,730,000 shares $9.06 million -3.3%N/A9.5 $1.92
1/15/20244,890,000 shares $11.78 million +4.7%N/A9.5 $2.41
12/31/20234,670,000 shares $11.49 million +4.7%N/A9.5 $2.46
12/15/20234,460,000 shares $9.41 million +0.2%N/A9.6 $2.11
11/30/20234,450,000 shares $7.88 million +8.0%N/A10.9 $1.77
11/15/20234,120,000 shares $6.63 million +1.0%N/A12.1 $1.61
10/31/20234,080,000 shares $6.00 million -7.3%N/A13.9 $1.47
10/15/20234,400,000 shares $7.26 million -5.2%N/A17.5 $1.65
9/30/20234,640,000 shares $7.89 million -6.8%N/A20.1 $1.70
9/15/20234,980,000 shares $10.36 million +2.1%N/A20.7 $2.08
8/31/20234,880,000 shares $12.25 million +3.2%N/A13.6 $2.51
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
8/15/20234,730,000 shares $12.91 million +1.9%N/A12.1 $2.73
7/31/20234,640,000 shares $13.87 million -1.1%N/A11.1 $2.99
7/15/20234,690,000 shares $12.66 million +1.5%N/A10.7 $2.70
6/30/20234,620,000 shares $13.86 million +25.9%N/A8.7 $3.00
6/15/20233,670,000 shares $13.73 million +1.7%N/A6.1 $3.74
5/31/20233,610,000 shares $11.37 million +0.6%N/A7.3 $3.15
5/15/20233,590,000 shares $13.89 million -5.0%N/A7.2 $3.87
4/30/20233,780,000 shares $12.74 million +16.7%N/A7.4 $3.37
4/15/20233,240,000 shares $11.66 million -10.3%N/A5.7 $3.60
3/31/20233,610,000 shares $9.67 million +10.4%N/A4.5 $2.68
3/15/20233,270,000 shares $8.37 million -0.6%N/A4.6 $2.56
2/28/20233,290,000 shares $9.80 million +13.8%N/A4.8 $2.98
2/15/20232,890,000 shares $9.88 million -0.3%N/A4.3 $3.42
1/31/20232,900,000 shares $10.99 million -10.8%N/A3.3 $3.79
1/15/20233,250,000 shares $11.25 million -21.9%N/A3.7 $3.46
12/30/20224,160,000 shares $34.32 million +2.2%N/A6.4 $8.25
12/15/20224,070,000 shares $36.51 million -5.1%N/A7.5 $8.97
11/30/20224,290,000 shares $47.23 million -3.6%N/A7.7 $11.01
11/15/20224,450,000 shares $39.16 million +10.2%N/A8 $8.80
10/31/20224,040,000 shares $27.84 million -20.6%N/A3.5 $6.89
10/15/20225,090,000 shares $35.07 million -1.0%N/A5.4 $6.89
9/30/20225,140,000 shares $39.58 million +27.5%N/A5.2 $7.70
9/15/20224,030,000 shares $34.46 million +7.8%N/A3.7 $8.55
8/31/20223,740,000 shares $32.58 million -32.9%N/A3.6 $8.71
8/15/20225,570,000 shares $44.56 million +27.2%N/A5.2 $8.00
7/31/20224,380,000 shares $14.89 million -9.5%N/A7.7 $3.40
7/15/20224,840,000 shares $20.38 million +19.5%N/A7.9 $4.21
6/30/20224,050,000 shares $11.54 million +2.3%N/A6.5 $2.85
6/15/20223,960,000 shares $10.49 million -1.5%N/A5.8 $2.65
5/31/20224,020,000 shares $9.69 million +2.6%N/A5.5 $2.41
5/15/20223,920,000 shares $9.02 million +1.8%N/A5.3 $2.30
4/30/20223,850,000 shares $13.40 million +5.8%N/A5.2 $3.48
4/15/20223,640,000 shares $14.56 million +1.7%N/A5.1 $4.00
3/31/20223,580,000 shares $17.90 million -5.0%N/A5 $5.00
3/15/20223,770,000 shares $18.93 million -4.8%N/A6.2 $5.02
2/28/20223,960,000 shares $25.66 million -6.2%N/A7.8 $6.48
2/15/20224,220,000 shares $29.58 million +6.6%N/A8.8 $7.01
1/31/20223,960,000 shares $37.86 million +12.8%N/A9.6 $9.56
1/15/20223,510,000 shares $44.33 million +9.0%N/A10.5 $12.63
12/31/20213,220,000 shares $63.21 million +4.2%N/A12.7 $19.63
12/15/20213,090,000 shares $65.11 million +16.2%N/A15.1 $21.07
11/30/20212,660,000 shares $67.17 million +10.4%N/A11.7 $25.25
11/15/20212,410,000 shares $65.50 million -13.9%N/A10.8 $27.18
10/29/20212,800,000 shares $81.84 million No ChangeN/A12.5 $29.23
10/15/20212,800,000 shares $79.38 million -3.5%N/A11.9 $28.35
9/30/20212,900,000 shares $85.38 million +7.0%N/A12.4 $29.44
9/15/20212,710,000 shares $99.89 million -6.6%N/A11.3 $36.86
8/31/20212,900,000 shares $119.16 million -2.4%N/A11.3 $41.09
8/13/20212,970,000 shares $122.39 million -7.5%N/A13.6 $41.21
7/30/20213,210,000 shares $131.58 million -3.3%N/A15.4 $40.99
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
7/15/20213,320,000 shares $125.46 million +0.6%N/A17 $37.79
6/30/20213,300,000 shares $139.85 million +11.1%N/A16.6 $42.38
6/15/20212,970,000 shares $117.73 million +8.8%N/A15.8 $39.64
5/28/20212,730,000 shares $117.53 million +1.5%N/A14.1 $43.05
5/14/20212,690,000 shares $122.61 million +13.5%12.8%11.4 $45.58
4/30/20212,370,000 shares $121.37 million +2.2%11.2%9.4 $51.21
4/15/20212,320,000 shares $106.81 million +11.5%12.9%8.8 $46.04
3/31/20212,080,000 shares $104.73 million +54.1%11.5%7.4 $50.35
3/15/20211,350,000 shares $89.65 million +63.6%7.5%4.6 $66.41
2/26/2021825,000 shares $44.57 million +28.2%4.6%2.5 $54.03
2/12/2021643,700 shares $34.24 million +641.6%3.6%2 $53.19
1/29/202186,800 shares $3.77 million +76.4%0.5%0.2 $43.47
1/15/202149,200 shares $2.29 million No Change0.3%0.1 $46.52

BCAB Short Interest - Frequently Asked Questions

What is BioAtla's current short interest?

Short interest is the volume of BioAtla shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 4,060,000 shares of BCAB short. 9.49% of BioAtla's shares are currently sold short. Learn More on BioAtla's current short interest.

What is a good short interest ratio for BioAtla?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCAB shares currently have a short interest ratio of 6.0. Learn More on BioAtla's short interest ratio.

Which institutional investors are shorting BioAtla?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioAtla: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for BioAtla?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.49% of BioAtla's floating shares are currently sold short.

Is BioAtla's short interest increasing or decreasing?

BioAtla saw a drop in short interest in April. As of April 15th, there was short interest totaling 4,060,000 shares, a drop of 6.2% from the previous total of 4,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does BioAtla's short interest compare to its competitors?

9.49% of BioAtla's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioAtla: ESSA Pharma Inc. (1.68%), Corbus Pharmaceuticals Holdings, Inc. (20.28%), Cellectis S.A. (0.73%), InflaRx (1.64%), IGM Biosciences, Inc. (5.47%), Telomir Pharmaceuticals, Inc. (12.06%), Biomerica, Inc. (0.72%), Context Therapeutics Inc. (4.49%), Caribou Biosciences, Inc. (11.73%), Sagimet Biosciences Inc. (16.46%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short BioAtla stock?

Short selling BCAB is an investing strategy that aims to generate trading profit from BioAtla as its price is falling. BCAB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioAtla?

A short squeeze for BioAtla occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCAB, which in turn drives the price of the stock up even further.

How often is BioAtla's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCAB, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:BCAB) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners